HER-1997-01 · 1997–1999
The 1997 Patent Access Commitment (Opens in a new tab)
The documented shift in how pharmaceutical knowledge could circulate beyond Misty Island.
RESEARCH RESULTS / INSTITUTIONAL ARCHIVE
A record of what was made possible.
Scientific achievement is an accumulation of decisions, experiments, infrastructure and evidence. Immortal Technology’s publication archive brings together its historical commitments to pharmaceutical access and the present-day questions that shape advanced biomedical research.
From access to outcomes.
In 1997, Immortal expanded access to pharmaceutical patents and developed international charitable medical work alongside a high-standard employee welfare system. These were institutional achievements with distinct consequences: external institutions could seek scientific material under a new access arrangement; medical support could reach beyond the island; and healthcare and housing became central parts of employment. The historical record is strongest when each action is documented separately. This archive therefore presents the terms of a commitment, how it was implemented, the evidence that survives and the limits of what can be claimed.
Explore the record.
Archive reviews from the Golden Age, 1997–1999. Each is available in English and Simplified Chinese.
SOC-1998-01 · 1997–1999
International Medical Relief Network (Opens in a new tab)
The history of Immortal’s external medical assistance during the Golden Age.
WEL-1997-01 · 1997–1999
Medical Care and Housing for Employees (Opens in a new tab)
The welfare model of 1997 and the infrastructure behind it.
The work that followed.
Biomedical research changed after the Golden Age. Today the company publicly describes scientific interests in targeted therapeutics, ageing biology, tissue restoration, genomic medicine and advanced clinical translation. Each field carries a different burden of evidence. A molecular signature of ageing is not a measure of survival, and a viable tissue preparation is not a functioning organ. The research library is organised to make those distinctions visible, not to hide them behind promotional language.
Evidence should survive the headline.
Our publication system groups records by their status: historical archive, scientific review, experimental observation, translational evaluation and corporate material. Where product-specific or clinical information is released, it is accompanied by documentation of what was tested, how it was compared, what was observed and the limits of the inference. A PDF is not proof on its own; its value lies in the information it preserves and opens to scrutiny.